- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Customised High-frequency oscillation effective against extratemporal epilepsy surgery: Lancet
In terms of intraoperative electrocorticography, High-frequency oscillation (HFO)-guided tailoring of epilepsy surgery was not superior to spike-guided tailoring, says an article published in The Lancet Neurology.
In order to customize epilepsy surgery, intraoperative electrocorticography examines interictal spikes or spike sequences that can identify tissue that is epileptogenic. With more specificity than spikes, high-frequency oscillations (HFOs) on intraoperative electrocorticography have been suggested as a novel biomarker of epileptogenic tissue. In order to determine if HFO-guided tailoring of epilepsy surgery is superior to spike-guided tailoring in terms of seizure freedom after one year, Willemiek Zweiphenning and colleagues prospectively evaluated this hypothesis.
The HFO study was an adaptive non-inferiority, single-blind, randomized experiment conducted at a Dutch epilepsy surgical center (UMC Utrecht). Those who had been recommended for intraoperative electrocorticography-tailored epilepsy surgery included children and adults of any age. Using an online randomization approach with permuted blocks created by an independent data manager and stratified by epilepsy type, participants were randomly assigned (1:1) to either HFO-guided or spike-guided tailoring. Participants and medical professionals who recorded seizure results were kept in the dark about treatment allocation, but neither the study team nor the neurosurgeon were. Surgical choices were always based on ictiform spike patterns. The main outcome was how many seizures there were after a year. It was decided to take a 10% risk difference non-inferiority margin. With predetermined subgroup analyses by epilepsy type and for confounders, the analysis was done with the purpose to treat.
The key findings of this study were:
78 people were randomly allocated to the research between October 10, 2014, and January 31, 2020. No loss existed for follow-up.
26 (67%) of the 39 individuals in the HFO-guided group and 35 (90%) of the 39 participants in the spike-guided group experienced seizure independence at one year.
Confounding factors were found to include pathology linked to poor prognosis, with an adjusted risk difference of -7.9%.
Eight significant adverse events requiring hospitalization were documented by the researchers (five in the HFO-guided group and three in the spike-guided group).
No patients passed away.
In conclusion, this study casts doubt on HFOs' clinical use as an epilepsy biomarker, particularly in cases of temporal lobe epilepsy. If HFO-guided intraoperative electrocorticography is effective in treating extratemporal lobe epilepsy, more investigation is required.
Reference:
Zweiphenning, W., Klooster, M. A. van 't, van Klink, N. E. C., Leijten, F. S. S., Ferrier, C. H., Gebbink, T., Huiskamp, G., van Eijsden, P., Otte, W. M., van Diessen, E., Braun, K. P. J., Zijlmans, M., … Dankbaar, J.-W. (2022). Intraoperative electrocorticography using high-frequency oscillations or spikes to tailor epilepsy surgery in the Netherlands (the HFO trial): a randomised, single-blind, adaptive non-inferiority trial. In The Lancet Neurology (Vol. 21, Issue 11, pp. 982–993). Elsevier BV. https://doi.org/10.1016/s1474-4422(22)00311-8
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751